Literature DB >> 3044156

Analysis and preparation of Bartonella bacilliformis antigens.

J Knobloch1.   

Abstract

Twenty-four antigens of Bartonella bacilliformis, a bacterium which causes bartonellosis in residents of high altitude valleys of the Andes, were identified by immunoblot and immunoprecipitation using rabbit anti-Bartonella sera as well as sera of patients. The antigens were designated according to their relative molecular mass which ranged from 16 to 160 kDa. Twelve antigens were detected by antibodies in sera of bartonellosis patients using immunoblot, of which six antigens were detected by immunoprecipitation. Antigens 25, 46, 65, 75, 99, and 160 were identified as probable cell wall antigens. Antigens 50, 65, and 75 detected long-persisting antibodies. Crude Bartonella antigen applied to ELISA reacted with anti-Chlamydia psittaci antibody as well as with antibody of unknown identity in human sera, whereas immunoblot and immunoprecipitation with Triton soluble antigens revealed Bartonella-specific results. Seven Bartonella antigens were prepared by high performance liquid chromatography of which one antigen (48 kDa) reacted Bartonella-specific when applied to ELISA. It was concluded that specificity of antibody determination with crude Bartonella antigen should be confirmed by either immunoblot or immunoprecipitation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044156     DOI: 10.4269/ajtmh.1988.39.173

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  The 75-kilodalton antigen of Bartonella bacilliformis is a structural homolog of the cell division protein FtsZ.

Authors:  I Padmalayam; B Anderson; M Kron; T Kelly; B Baumstark
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

2.  An evaluation study of enzyme-linked immunosorbent assay (ELISA) using recombinant protein Pap31 for detection of antibody against Bartonella bacilliformis infection among the Peruvian population.

Authors:  Nasikarn Angkasekwinai; Erin H Atkins; Sofia Romero; John Grieco; Chien Chung Chao; Wei Mei Ching
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

3.  Sonicated diagnostic immunoblot for bartonellosis.

Authors:  V Mallqui; E C Speelmon; M Verástegui; C Maguiña-Vargas; P Pinell-Salles; R Lavarello; J Delgado; M Kosek; S Romero; Y Arana; R H Gilman
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

Review 4.  Bartonella spp. as emerging human pathogens.

Authors:  B E Anderson; M A Neuman
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 5.  Carrion's Disease: the Sound of Silence.

Authors:  Cláudia Gomes; Joaquim Ruiz
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

6.  Proteomic and immunoblot analyses of Bartonella quintana total membrane proteins identify antigens recognized by sera from infected patients.

Authors:  Jenni K Boonjakuakul; Helen L Gerns; Yu-Ting Chen; Linda D Hicks; Michael F Minnick; Scott E Dixon; Steven C Hall; Jane E Koehler
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

7.  Serodiagnosis of Bartonella bacilliformis infection by indirect fluorescence antibody assay: test development and application to a population in an area of bartonellosis endemicity.

Authors:  J Chamberlin; L Laughlin; S Gordon; S Romero; N Solórzano; R L Regnery
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

8.  Detection of Rickettsia prowazekii in body lice and their feces by using monoclonal antibodies.

Authors:  Rong Fang; Linda Houhamdi; Didier Raoult
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Use of the cell division protein FtsZ as a means of differentiating among Bartonella species.

Authors:  T M Kelly; I Padmalayam; B R Baumstark
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Susceptibility of owl monkeys (Aotus nancymaae) to experimental infection with Bartonella bacilliformis.

Authors:  David E Bentzel; Benjamin J Espinosa; Enrique Canal; David L Blazes; Eric R Hall
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.